via Nano Magazine
HZDR researchers trace cancer cells with tailor-made materials
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells. They can navigate directly to the tumor cells and visualize those using advanced imaging techniques. Both in petri dishes and animal models, the scientists were able to effectively guide the nanoparticles to the cancer cells. The next step is to combine the new technique with therapeutic approaches.
The HZDR researchers start out with tiny, biocompatible nanoparticles made of so-called dendritic polyglycerols that serve as carrier molecules. “We can modify these particles and introduce various functions,” explains Dr. Kristof Zarschler, research associate at HZDR’s Institute of Radiopharmaceutical Cancer Research. “For example, we can attach an antibody fragment to the particle that specifically binds to cancer cells. This antibody fragment is our targeting moiety that directs the nanoparticle to the tumor.”
The target of the modified nanoparticles is an antigen known as EGFR (epidermal growth factor receptor). In certain types of cancer, such as breast cancer or head and neck tumors, this protein is overexpressed on the surface of the cells. “We were able to show that our designed nanoparticles preferentially interact with the cancer cells via these receptors,” confirms Dr. Holger Stephan, leader of the Nanoscalic Systems Group at HZDR. “In control tests with similar nanoparticles that had been modified with an unspecific antibody, significantly fewer nanoparticles accumulated at the tumor cells.”
The scientists intensively studied the nanoparticles’ behavior both in cell cultures and in an animal model. For this purpose, they provided the nanoparticles with additional reporter characteristics, as Kristof Zarschler explains: “We used two complementary possibilities. In addition to the antibodies, we attached dye molecules and radionuclides to the nanoparticles. The dye molecule emits in the near infrared spectrum that penetrates the tissue and can be visualized with an appropriate microscope. The dye thus reveals where exactly the nanoparticles are located.” The radionuclide, copper-64, fulfils a similar purpose. It emits radiation that is detected by a PET scanner (positron emission tomography). The signals can then be converted into a three-dimensional image that visualizes the distribution of the nanoparticles in the organism.
Excellent properties in living organisms
Using these imaging techniques, researchers have been able to show that nanoparticle accumulation in the tumor tissue reaches maximum two days after administration to mice. The labelled nanoparticles are subsequently eliminated via the kidneys without being a burden for the body. “They are apparently ideal in size and properties,” says Holger Stephan. “Smaller particles are filtered out of the blood in just a few hours and thus only have a short-term impact. If, on the other hand, the particles are too big, they accumulate in the spleen, liver or lungs and cannot be removed from the body via the kidneys and bladder.” The interplay between the nanoparticles with an exact size of three nanometers and the attached antibody fragments evidently has a positive influence on the distribution and retention of the antibody in the organism as well as on its excretion profile.
In future experiments, the HZDR researchers want to test whether they can modify their system to carry other components. Kristof Zarschler describes the plans: “You can take these nanoparticles and functionalize them with an active substance. Then you can deliver a drug directly to the tumor. This might be a therapeutic radionuclide that destroys the tumor cells.” It is also possible to attach antibody fragments specific for proteins other than EGFR to target different types of cancer.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- New Tech Could Help Prevent COVID-19 Spread in Public Spaceson June 19, 2020 at 9:16 am
As businesses and public spaces around the world reopen amid the COVID-19 pandemic—despite second waves of infection already emerging in some areas—researchers are working on several key technologies ...
- Nanoparticle for overcoming leukemia treatment resistanceon June 18, 2020 at 9:43 am
A research team found that repurposing a commonly used chemotherapy drug using a nanoparticle was more effective than both a solution of the pure drug and other available treatments. UConn ...
- College of Science postdoc is lead author on cover article of Royal Society of Chemistry journalon June 17, 2020 at 8:54 am
Collaborative research by Clemson postdoc Mohamed Attia and associate professor Daniel Whitehead is featured on the cover of the June 7 issue of the Royal Society of Chemistry’s Biomaterials Science ...
- Applications of Upconversion Nanoparticles in Imaging, Detection and Therapyon June 15, 2020 at 5:00 pm
These therapies are made possible due to the fact that the nanoparticles can be easily modified for specific targeting and delivery. In this method, UCNs allows synergistic treatments as they ...
- Can Leptin-derived Sequence-modified Nanoparticles be Suitable Tools for Brain Delivery?on June 15, 2020 at 5:00 pm
Surface Modification of the NPs Both NP-P and TMR-NP-P were modified on the surface according ... stored for further conjugation with thiolated nanoparticles (NP-SH or TMR-NP-SH).
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- NIH grant to bioprint nanoparticles for ovarian cancer immunotherapyon June 19, 2020 at 12:13 pm
The particles will be produced using 3D-bioprinting, enabling them to be released at specified intervals, instead of a continuous slow release.
- ChemoRad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiationon June 18, 2020 at 5:00 pm
In this study, we report the development of a novel NP (nanoparticle) therapeutic, ChemoRad NP, which can deliver biologically targeted chemoradiation. Method: A biodegradable and biocompatible ...
- Scientists Find a Way to Improve the Efficiency of Chemotherapyon June 13, 2020 at 5:00 pm
The nanoparticles carrying the drug were enriched ... conducted a series of experiments on the binding of doxorubicin with biocompatible boron nitride nanoparticles, which perfectly bind with ...
- Materials Research Gets Under the Skinon June 11, 2020 at 5:00 pm
Scientists push biocompatible materials to interact with their surroundings in intelligent ways ...
- Nanomedicine Strategies for Hematological Malignancies: What Is Next?on June 10, 2020 at 5:00 pm
as well as to decrease its accumulation in nontargeted regions through surface modification with biocompatible and biodegradable polymers. Due to their unique features, nanoparticles have the ...